Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), today announced plans for a 76,000 sq. ft. commercial-ready manufacturing facility for cell therapies and gene-modified cell therapies. Located in The

Cellipont Bioservices, a cell therapy contract development and manufacturing organization (CDMO), today announced plans to expand its development and manufacturing facility at its Poway, California location. The expansion will enable Cellipont to